Literature DB >> 1330366

Experimental models that mimic the differentiation and dedifferentiation of vascular cells.

R R Pauly1, A Passaniti, M Crow, J L Kinsella, N Papadopoulos, R Monticone, E G Lakatta, G R Martin.   

Abstract

Endothelial and smooth muscle cells normally exist in a quiescent differentiated state. After injury to the vessel, these cells dedifferentiate, migrate, and proliferate as needed for repair. In culture on plastic, both endothelial and smooth muscle cells exhibit the dedifferentiated phenotype. We have found that laminin and reconstituted basement membrane proteins (Matrigel) induce a very rapid cessation of endothelial cell proliferation followed by alignment and subsequent reorganization into tubelike structures. We have also found that smooth muscle cells in culture exhibit a differentiated phenotype when exposed to Matrigel. The molecular mechanisms involved in smooth muscle differentiation resemble those of skeletal muscle, in which proliferation and differentiation appear to be mutually exclusive states controlled by both positive and negative transcriptional regulators. The dedifferentiated smooth muscle cells produce proteases and exhibit a migratory and invasive phenotype capable of destroying normal tissue architecture. These studies suggest that the modulation of endothelial and smooth muscle cells between a differentiated and dedifferentiated phenotype is regulated by extracellular matrix components as well as by cytokines. Model systems such as those described here should allow the identification of molecular events controlling the differentiation of vascular cells and facilitate the development of therapeutic agents that maintain healthy vessels.

Mesh:

Substances:

Year:  1992        PMID: 1330366

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  18 in total

1.  Central Arterial Aging and Angiotensin II Signaling.

Authors:  Mingyi Wang; Benjamin Khazan; Edward G Lakatta
Journal:  Curr Hypertens Rev       Date:  2010-11-01

Review 2.  In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents.

Authors:  Anne M Goodwin
Journal:  Microvasc Res       Date:  2007-06-06       Impact factor: 3.514

3.  Endothelial cell invasion by Toxoplasma gondii: differences between cell types and parasite strains.

Authors:  Irma Cañedo-Solares; Montserrat Calzada-Ruiz; Luz Belinda Ortiz-Alegría; Alda Rocío Ortiz-Muñiz; Dolores Correa
Journal:  Parasitol Res       Date:  2013-06-10       Impact factor: 2.289

Review 4.  Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons.

Authors:  Edward G Lakatta
Journal:  Heart Fail Rev       Date:  2002-01       Impact factor: 4.214

5.  Vitamin D improves the angiogenic properties of endothelial progenitor cells.

Authors:  M Grundmann; M Haidar; S Placzko; R Niendorf; N Darashchonak; C A Hubel; F von Versen-Höynck
Journal:  Am J Physiol Cell Physiol       Date:  2012-08-29       Impact factor: 4.249

Review 6.  Proinflammation: the key to arterial aging.

Authors:  Mingyi Wang; Liqun Jiang; Robert E Monticone; Edward G Lakatta
Journal:  Trends Endocrinol Metab       Date:  2013-12-20       Impact factor: 12.015

Review 7.  Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels.

Authors:  Edward G Lakatta; Mingyi Wang; Samer S Najjar
Journal:  Med Clin North Am       Date:  2009-05       Impact factor: 5.456

8.  Enhanced cytomegalovirus infection in atherosclerotic human blood vessels.

Authors:  Pamela L Nerheim; Jeffery L Meier; Mohammad A Vasef; Wei-Gen Li; Ling Hu; James B Rice; Daniel Gavrila; Wayne E Richenbacher; Neal L Weintraub
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

9.  Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs).

Authors:  Zhaodi Gong; Laura E Niklason
Journal:  FASEB J       Date:  2008-01-16       Impact factor: 5.191

Review 10.  Arterial aging: a journey into subclinical arterial disease.

Authors:  Mingyi Wang; Robert E Monticone; Edward G Lakatta
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-03       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.